Concepedia

A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer

Mark N. Levine, Chu‐Shu Gu, Howard A. Liebman, C. P. Escalante, Susan Solymoss, David Deitchman, Luz M. Ramirez, Jim A. Julian

Journal of Thrombosis and Haemostasis · 2012 · 190 citations · 12 references

DOIFull text

Open access

Concepts

References

12

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients

Sam Schulman, Clive Kearon · Journal of Thrombosis and Haemostasis · 2005 · 4.9K citations

, , +12

Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial

Michael R. Lassen, Gary E. Raskob, Alexander Gallus et al. · The Lancet · 2010 · 777 citations

, , +15

Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement

Michael R. Lassen, Alexander Gallus, Gary E. Raskob et al. · New England Journal of Medicine · 2010 · 775 citations

, , +17

Apixaban or Enoxaparin for Thromboprophylaxis after Knee Replacement

Michael R. Lassen, Gary E. Raskob, Alexander Gallus et al. · New England Journal of Medicine · 2009 · 694 citations · Full text

, , +17

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

Giancarlo Agnelli, Gualberto Gussoni, C. Bianchini et al. · The Lancet Oncology · 2009 · 598 citations

, , +13